Tomohiro, D. Et Al. 2011. Combination of the Tumor Angiogenesis Inhibitor Bevacizumab and Intratumoral Oncolytic Herpes Virus Injections as a Treatment Strategy for Human Gastric Cancers. HEPATO-GASTROENTEROLOGY , vol.59, no.118 , 1844-1850.

Tomohiro, D., Shikano, T., Kasuya, H., Akihiro, N., Fujiwara, S., Takeda, S., ... Gewen, T.(2011). Combination of the Tumor Angiogenesis Inhibitor Bevacizumab and Intratumoral Oncolytic Herpes Virus Injections as a Treatment Strategy for Human Gastric Cancers. HEPATO-GASTROENTEROLOGY , vol.59, no.118, 1844-1850.

Tomohiro, Deguchi Et Al. "Combination of the Tumor Angiogenesis Inhibitor Bevacizumab and Intratumoral Oncolytic Herpes Virus Injections as a Treatment Strategy for Human Gastric Cancers," HEPATO-GASTROENTEROLOGY , vol.59, no.118, 1844-1850, 2011

Tomohiro, Deguchi Et Al. "Combination of the Tumor Angiogenesis Inhibitor Bevacizumab and Intratumoral Oncolytic Herpes Virus Injections as a Treatment Strategy for Human Gastric Cancers." HEPATO-GASTROENTEROLOGY , vol.59, no.118, pp.1844-1850, 2011

Tomohiro, D. Et Al. (2011) . "Combination of the Tumor Angiogenesis Inhibitor Bevacizumab and Intratumoral Oncolytic Herpes Virus Injections as a Treatment Strategy for Human Gastric Cancers." HEPATO-GASTROENTEROLOGY , vol.59, no.118, pp.1844-1850.

@article{article, author={Deguchi Tomohiro Et Al. }, title={Combination of the Tumor Angiogenesis Inhibitor Bevacizumab and Intratumoral Oncolytic Herpes Virus Injections as a Treatment Strategy for Human Gastric Cancers}, journal={HEPATO-GASTROENTEROLOGY}, year=2011, pages={1844-1850} }